Jump to Content
Jump to Main Navigation
User Account
Sign In
to save searches and organize your favorite content.
Not registered?
Sign up
My Content
(0)
Recently viewed
(0)
Save Entry
Searches
(0)
Recently viewed
(0)
Save Search
More
Subscriptions
Join E-mail List
Help
JNCCN
Menu
Home
Content
Current Issue
Past Issues
Online First
Supplements
NCCN Meeting Highlights
JNCCN In the News
COVID-19
CE
JNCCN 360
Author Center
Call for Papers
Submit a Manuscript
Information for Authors
Reprints/Permissions
About
JNCCN
Editorial Board
Editorial Calendar
NCCN
Harborside
Search
Close
Advanced Search
Help
Volume 9 (2011): Issue 12 (Dec 2011)
in
Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Get eTOC Alerts
Get Ahead of Print Alerts
Get Citation Alerts
NCCN News
Pages: xxiv–xxv
Erratum
Pages: xxv
Oncology Research Program
Pages: xxxv–xxxvi
Avastin for Breast Cancer, 2005-2011: Requiescat in Pacem?
By:
Harold J. Burstein
Pages: 1321–1323
Incorporation of Crizotinib into the NCCN Guidelines
By:
Gregory J. Riely
,
Jamie E. Chaft
,
Marc Ladanyi
, and
Mark G. Kris
Pages: 1328–1330
The Changing Paradigm of Treating Pancreatic Neuroendocrine Tumors
By:
Renuka Iyer
and
Kaunteya Reddy
Pages: 1331–1333
Crizotinib and Testing for ALK
By:
Alice T. Shaw
,
Benjamin Solomon
, and
Mari Mino Kenudson
Pages: 1335–1341
Effort Tracking Metrics Provide Data for Optimal Budgeting and Workload Management in Therapeutic Cancer Clinical Trials
By:
Pam James
,
Patricia Bebee
,
Linda Beekman
,
David Browning
,
Mathew Innes
,
Jeannie Kain
,
Theresa Royce Westcott
, and
Marcy Waldinger
Pages: 1343–1352
Occult Primary
By:
David S. Ettinger
,
Mark Agulnik
,
Justin M. M. Cates
,
Mihaela Cristea
,
Crystal S. Denlinger
,
Keith D. Eaton
,
Panagiotis M. Fidias
,
David Gierada
,
Jon P. Gockerman
,
Charles R. Handorf
,
Renuka Iyer
,
Renato Lenzi
,
John Phay
,
Asif Rashid
,
Leonard Saltz
,
Lawrence N. Shulman
,
Jeffrey B. Smerage
,
Gauri R. Varadhachary
,
Jonathan S. Zager
, and
Weining (Ken) Zhen
Pages: 1358–1395
Management of Neuroendocrine Tumors of Unknown Origin
By:
Ariel Polish
,
Maxwell T. Vergo
, and
Mark Agulnik
Pages: 1397–1402
Carcinoma of Unknown Primary: Focused Evaluation
By:
Gauri R. Varadhachary
Pages: 1406–1412
Gene Expression Analysis and Immunohistochemistry in Evaluation of Cancer of Unknown Primary: Time for a Patient-Centered Approach
By:
Charles R. Handorf
Pages: 1415–1420
Save
Email this content
Share Link
Copy this link, or click below to email it to a friend
Email this content
or copy the link directly:
https://jnccn.org/view/journals/jnccn/9/12/jnccn.9.issue-12.xml
The link was not copied. Your current browser may not support copying via this button.
Link copied successfully
Copy link
Collapse
Expand
Search
Issue
Journal
[3.236.55.22]
3.236.55.22
Sign in to annotate
Close
Edit
Character limit
500
/500
Delete
Cancel
Save
@!
Character limit
500
/500
Cancel
Save
